Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Lewallen

Orthopaedic Surgery Rochester, MN Medical Doctor

NPI 1801874920 CMS profile 81462

200 1St St Sw, Rochester, MN 55905

Open in the dashboard

General payments

$7,961,886

99 records reported · program years 2019–2025

Research payments

$9,051

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$467,159

1 holding reported · through program year 2025

Through program year 2025, David Lewallen of Rochester, MN is reported in the CMS Open Payments database as having received $7,961,886 across 99 general payments and $9,051 in research payments paid to them. They also declared ownership or investment interests valued at $467,159 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,457 2
2024 General $2,375 4
2024 Research $2,213 1
2023 General $4,857,580 4
2022 General $1,272,965 8
2021 General $32,847 27
2020 General $865,300 9
2020 Research $6,838 2
2019 General $929,363 45
2025 Ownership $467,159 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Lewallen
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to David Lewallen were reported at $1,457. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year David Lewallen Orthopaedic Surgery median Middle half National median
2019 $929,363 $644 $140–$2,844 $163
2020 $865,300 $312 $75–$1,860 $114
2021 $32,847 $520 $117–$2,495 $132
2022 $1,272,965 $598 $128–$2,731 $149
2023 $4,857,580 $461 $128–$2,264 $160
2024 $2,375 $497 $134–$2,475 $164
2025 $1,457 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $7,961,415 97 payments
  2. Acuitive Technologies, Inc $457 1 payment
  3. MicroPort Orthopedics Inc $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $7,901,570 18 payments
  2. Consulting Fee $57,000 46 payments
  3. Travel and Lodging $1,937 13 payments
  4. Food and Beverage $1,379 22 payments
Products named General payments · program years 2019–2025
  1. Persona Knees $6,129,294 10 payments
  2. Persona Knees $1,772,276 8 payments
  3. Trabecular Metal (TM) $19,250 5 payments
  4. Hips Product Portfolio $3,324 8 payments
  5. PD-Hip-New Product $2,750 5 payments
  6. Arcos $616 2 payments
  7. Connected Health-MyMobility $375 1 payment
  8. G7 $123 3 payments
  9. TM Augments Revision $119 1 payment
  10. Connected Health Product Portfolio $93 1 payment
  11. Other $42 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. OMNIlife science, Inc $6,838 2 payments
  2. Amgen Inc. $2,213 1 payment

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record